H. Lankau

发表

Highly potent, selective, and orally active phosphodiesterase 10A inhibitors.

U. Egerland, N. Hoefgen, M. Malamas, 2011, Journal of medicinal chemistry.

3‐Amino‐ and 5‐Aminopyrazoles with Anticonvulsant Activity

H. Lankau, K. Unverferth, C. Rundfeldt, 1999, Archiv der Pharmazie.

New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity.

U. Egerland, H. Lankau, C. Grunwald, 2007, European journal of medicinal chemistry.

Synthesis, pharmacology, and structure-activity relationships of novel imidazolones and pyrrolones as modulators of GABAA receptors.

U. Egerland, H. Lankau, C. Grunwald, 2006, Journal of medicinal chemistry.

Synthesis, anticonvulsant activity, and structure-activity relationships of sodium channel blocking 3-aminopyrroles.

H. Lankau, A. Rolfs, H. Hofmann, 1998, Journal of medicinal chemistry.

3-AMINO-2(1H)-QUINOLONES BY CYCLIZATION OF N-ACYLATED ANTHRANILIC ACID DERIVATIVES

H. Lankau, K. Unverferth, K. Gewald, 1997 .

Nouvelle 4-amino-1-aryl-pyridine-2-one a proprietes anticonvulsivantes et son procede de fabrication

H. Lankau, K. Unverferth, V. Granik, 1999 .

Discovery of imidazo[1,5-a]pyrido[3,2-e]pyrazines as a new class of phosphodiesterase 10A inhibitiors.

Christian Grunwald, Ute Egerland, U. Egerland, 2010, Journal of medicinal chemistry.

Novel triazines as potent and selective phosphodiesterase 10A inhibitors.

U. Egerland, N. Hoefgen, M. Malamas, 2012, Bioorganic & medicinal chemistry letters.

Novel triazines as potent and selective phosphodiesterase 10A inhibitors.

U. Egerland, N. Hoefgen, M. Malamas, 2012, Bioorganic & medicinal chemistry letters.